Talis Announces Fourth Quarter and Full Year 2022 Financial Results
March 22, 2023 16:05 ET
|
Talis Biomedical Corporation
REDWOOD CITY, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of...
Talis Biomedical Reports Third Quarter 2022 Financial Results
November 03, 2022 16:05 ET
|
Talis Biomedical Corporation
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of...
Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results
August 02, 2022 16:05 ET
|
Talis Biomedical Corporation
REDWOOD CITY, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical Announces First Quarter 2022 Financial Results
May 10, 2022 16:05 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022
April 26, 2022 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious...
Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
March 15, 2022 16:05 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022
March 01, 2022 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious...
Talis Biomedical Announces Leadership Transition
December 08, 2021 08:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2021 17:00 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
November 15, 2021 16:05 ET
|
Talis Biomedical Corporation
MENLO PARK, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...